Cargando…
Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma
The aim of this study was to investigate the prognostic impact of baseline tumor burden and loci on the efficacy of first line renal cancer treatment with sunitinib. Baseline and on-treatment CT scans were evaluated. Both the Kaplan-Meier and Weibull modelling survival estimators have been used to d...
Autores principales: | Czarnecka, Anna M., Brodziak, Anna, Sobczuk, Pawel, Dendek, Cezary, Labochka, Dominika, Korniluk, Jan, Bartnik, Ewa, Szczylik, Cezary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533291/ https://www.ncbi.nlm.nih.gov/pubmed/31123336 http://dx.doi.org/10.1038/s41598-019-44226-y |
Ejemplares similares
-
Renal cell carcinoma with intramyocardial metastases
por: Czarnecka, Anna M, et al.
Publicado: (2014) -
Renin angiotensin system deregulation as renal cancer risk factor
por: Sobczuk, Paweł, et al.
Publicado: (2017) -
Thyroid Hormones as Renal Cell Cancer Regulators
por: Szymański, Łukasz, et al.
Publicado: (2016) -
Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma
por: Chrom, Pawel, et al.
Publicado: (2018) -
Metastatic renal cell carcinoma cells growing in 3D on poly-D-lysine or laminin present a stem-like phenotype and drug resistance
por: Brodaczewska, Klaudia K., et al.
Publicado: (2019)